Luke Johnson has a diverse work experience spanning multiple industries. Luke is currently the Co-Founder and CEO of Capexpert, a position they have held since April 2021. Prior to this, they worked at DocVocate from November 2019 onwards, focusing on Surgery Center Growth Strategy.
Luke also has experience at American Orthopedic Partners, LLC, where they served as the Senior Director of Business Development from September 2021 to April 2022. Before that, they were the Director of Business Development at ValueHealth LLC from June 2020 to August 2021.
In their previous roles, Luke worked at Surgery Partners, Inc as the Director of Business Development from August 2018 to March 2020, and at Cardinal Health as an ASC Sales Consultant for the San Diego area. Luke also held roles at Cardinal Health as part of the Sales Leadership Development and Operations, Capital Projects Team.
Additionally, Luke has experience as the Program Director and Consultant at the Luke Johnson QB Receiver Academy at Peak Performance of Dublin in 2016. Luke also worked as a Capstone Consultant for Crane Co. at the University of Dayton from August 2014 to April 2015, and as a Sales and Marketing Intern at Hillerich & Bradsby Co. in 2014.
Early in their career, Luke worked in Suite Operations at Dayton Dragons Professional Baseball from March 2013 to April 2014. Overall, Luke Johnson has demonstrated a range of skills and experiences in business development, strategy, and consultancy across various industries.
Luke Johnson began their education at the University of Dayton in 2011, where they obtained a Bachelor of Science (B.S.) degree. Luke'sfield of study during their undergraduate years is unknown. Luke then went on to pursue a degree in Operations and Supply Chain Management at the University of Dayton from 2012 to 2015. Following their undergraduate studies, Luke attended the UCLA Anderson School of Management from 2018 to 2021. There, they earned a Master of Business Administration (MBA) degree with a focus on Entrepreneurship/Entrepreneurial Studies.
April, 2021 - present